Mann R A, Schiff D, Jetzt A E, Ron Y, Singh M, Singh A B
The Department of Medicine, The University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, New Jersey, 08903, USA.
Clin Immunol Immunopathol. 1998 Dec;89(3):260-70. doi: 10.1006/clin.1998.4611.
Murine graft-versus-host (GVH) disease takes two forms depending upon the parental/F1 strain combination employed. Anemia, lymphopenia, hypogammaglobulinemia, profound anti-F1 cytotoxicity, and the loss of cytotoxic potential against third party alloantigen is seen in acute lethal GVH disease. In contrast to this, in chronic GVH disease there is polyclonal B cell activation, auto-antibody production, no anti-F1 cytotoxicity, and retained cytotoxicity against allotargets. We have previously reported that this marked disparity in disease expression results from a radiosensitive host veto cell which protects the F1 mouse from parental anti-F1 cytotoxicity in mice undergoing CGVH disease. This cell could be induced in vitro or in vivo in CGVH disease. Using an in vitro system, we now demonstrate that a CD4(+), radiation-sensitive, T cell does emerge in acute lethal GVH disease which is capable of down-regulating cytotoxicity. The cell does not appear to be a veto cell in that it attenuates cytotoxicity directed against nonself alloantigen. The function of this cell does not appear to be influenced by minor lymphocyte stimulatory gene products. We further report that, in ALGVH disease, regulation by this cell is not readily apparent due to the emergence of a CD8(+) T cell of parental (B6) origin, which opposes its action.
小鼠移植物抗宿主(GVH)病根据所采用的亲代/F1品系组合有两种形式。在急性致死性GVH病中可见贫血、淋巴细胞减少、低丙种球蛋白血症、强烈的抗F1细胞毒性以及针对第三方同种异体抗原的细胞毒性潜能丧失。与此相反,在慢性GVH病中存在多克隆B细胞活化、自身抗体产生、无抗F1细胞毒性以及对同种异体靶标的细胞毒性得以保留。我们先前曾报道,疾病表现的这种显著差异是由一种放射敏感的宿主否决细胞引起的,该细胞在经历慢性GVH病的小鼠中保护F1小鼠免受亲代抗F1细胞毒性的影响。这种细胞可在慢性GVH病的体外或体内诱导产生。利用体外系统,我们现在证明在急性致死性GVH病中确实出现了一种CD4(+)、对辐射敏感的T细胞,它能够下调细胞毒性。该细胞似乎不是否决细胞,因为它减弱了针对非自身同种异体抗原的细胞毒性。该细胞的功能似乎不受次要淋巴细胞刺激基因产物的影响。我们进一步报道,在急性致死性GVH病中,由于亲代(B6)来源的CD8(+) T细胞的出现,该细胞的调节作用并不明显,因为这种CD8(+) T细胞会对抗其作用。